Stock On Alert! AMEL, PWRM, CRWE, Live Lithium Stock Tickers

Report by Richard Mowat

View the complete AMEL chart at WikinvestFollow @StocksOnAlert For Up To Date Data On This Company!

** AMEL reported that it has received its 2nd draw down from its million finance agreement on April 29, 2010 to accelerate AMEL’s ongoing US exploration system on its Paymaster Project in Nevada.

AMEL’s Paymaster Project represents a five,880-acre claim block adjacent to the Clayton Valley playa, in which lithium-rich brines and evaporates have been accumulating for a lot more than 30,000 many years, resulting in the highest lithium content located in any brines tested by the US Geological Survey (USGS) in southwestern US playas and basins.

In addition: – AMEL lately executed a definitive agreement therefore acquiring 100% of the assets of the five,280-acre (eight.25 square mile) Clayton Deep Lithium brine project, covering the complete Southwest Gravity Reduced in Clayton Valley, NV.

– AMEL just lately executed a definitive agreement thereby acquiring a hundred% of the assets of the five,760-acre (9 square mile) Full Monty project in Nye County, NV. The federal placer mining claims lie 25 miles north of Clayton Valley’s prime Lithium-mining area.

__ PWRM, Power three Medical Merchandise (PWRM .068 ↑11.48%) Inc., PWRM.OB Stem cell treatment options are a kind of genetic medicine that introduce new cells into damaged tissue in order to treat a illness or injury.

View the total PWRM chart at Wikinvest

Numerous medical researchers think that stem cell therapies have the prospective to alter the face of human disease and alleviate suffering. The capability of stem cells to self-renew and give rise to subsequent generations that can differentiate, delivers a significant possible to culture tissues that can substitute diseased and broken tissues in the physique, with no the risk of rejection and side effects.PWRM is a leader in bio-health-related investigation and the commercialization of biomarkers, tests, and mechanisms of condition. Power3’s patent-pending technologies are being used to create screening and diagnostic tests for the early detection and prognosis of condition, identify protein biomarkers, and drug targets, to fulfill vital unmet wants in areas like neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro).

Last February, PWRM entered into a definitive merger agreement to obtain StemTroniX, Inc.

StemTroniX, Inc. is a stem cell biotechnology acquisition and holding firm that is committed to enhancing the lives of men and women by utilizing autologous adult stem cell engineering to repair tissue damage in patients.

Autologous adult stem cell therapy is the approach of employing an individual’s own stem cells for the objective of repairing and regenerating broken tissue. StemTroniX also gives a patented program to augment this method in a non-invasive method for in-entire body monitoring of the stem cells at the internet site of injury as they are staying introduced into the patients.

** The principals of StemTroniX and PWRM has been filed in a joint provisional patent application entitled, “Stem Cell Protein Biomarkers and Their Use in Monitoring Stem Cells and Their Products for Stem Cell Treatment” with the United States Patent and Trademark Office.

It obviously claims in no uncertain terms how medical practices and scientific methods will improve modern and future regenerative medicine technologies by exactly identifying the certain stem cells to be transplanted with protein biomarkers.

__ CRWE, Crown Equity Holdings (CRWE .16 ↑0.00%), Inc., CRWE.OB CRWE is a consulting organization which supplies and assists small enterprise owners with the expertise necessary in taking their company public, and has re-focused its principal vision with its aligned group of independent website divisions to delivering media marketing services, as a globally on the internet media marketing publisher, dedicated to the distribution of top quality branding details, as well as search engine optimization for its clientele.

View the complete CRWE chart at Wikinvest

– CRWE fiscal data for the year ending 2009 – ** CRWE’s income for the year totaled 9,907 compared to ,190 for the duration of 2008. Net income following taxes in 2009 was ,927 compared to a net loss of 6,131 in 2008 with operating capital escalating by 2,341 in 2009.CRWE has expanded its net footprint internationally to incorporate the following 20 nations Argentina, Australia, Brazil, Canada, China, France, French-Canadian, Germany, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, New Zealand, Singapore, Spain, Taiwan and the UK.

__ ***Totally free Every day STOCK ALERTS** Sign up to receive Cost-free stock alerts from at About is a stock view website, a Crown Equity Holdings, Inc. division that provides totally free daily alerts on stocks.’s alerts are daily e-mail on stocks that are hot in the marketplace. These contain stocks with massive volume, penny stocks, stocks with technical indicators and much far more. also tracks tiny cap stocks that are on the brink of moving upwards. also features companies on its site with study report, evaluation, and newsletters. is an independent electronic publication that gives data on selected publicly traded firms. is not a registered investment advisor or broker-dealer. and Crown Equity Holdings, Inc., affiliates, officers, directors, contractors and employees, including may possibly acquire and sell extra shares in any organization mentioned herein and may possibly profit in the occasion those shares rise in worth. Please do your own Due Diligence just before investing in any of the stocks talked about over.

THIS IS NOT A RECOMMENDATION TO Acquire OR Sell ANY Safety! Please do your own Due Diligence just before investing in any of the stocks talked about over. Never invest in any stock featured on our internet site or emails unless you can afford to drop your complete investment. The disclaimer is to be read and totally understood prior to using our web sites, stock alerts, view list or joining our e-mail list. is owned by Crown Equity Holdings, Inc. who has previously received 5 hundred thousand shares compensation for 30 days of advertisement solutions and received an extra 1,000,000 shares 144 restricted stocks for a continuation of six months of advertisement and disseminating news, as nicely as ,000 dollars for IR solutions for Energy three Health-related Products Inc. (PWRM.OB). Not too long ago, Crown Equity Holdings, Inc has received an further amount of two,000,000 shares of cost-free trading stock for 60 days media advertisement, net style and upkeep for Power 3 Health-related Products Inc. (PWRM.OB). Full disclaimer can be read at

Release of Liability: By means of use of our internet site, E mail Alerts, and stock alerts viewing or utilizing, you agree to hold, Crown Equity Holdings, Inc., its operators, shareholders, consultants, associates and workers harmless and to totally release them from any and all liability due to any and all loss (monetary or otherwise), harm (monetary or otherwise), or injury (monetary or otherwise) that you may possibly incur. The information contained herein is based on sources which we believe to be dependable but is not assured by us as being correct and does not purport to be a complete statement or summary of the obtainable information. and Crown Equity Holdings, Inc. affiliates and associates might from time to time have a position in the securities mentioned herein and may enhance or reduce such positions without having notice. Crown Equity Holdings, Inc. encourages readers and investors to supplement the details in these reports with independent research and other specialist guidance. All info on featured businesses is provided by the companies profiled, or is offered from public sources and makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled firms.

Forward Looking Statement This press release contains “forward-looking statements” within the that means of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future efficiency and involve important dangers and uncertainties. Actual final results may fluctuate materially from individuals in the forward-hunting statements as a outcome of the effectiveness of management’s techniques and decisions, general financial and organization problems, new or modified statutory or regulatory needs and modifying price tag and market place conditions. No assurance can be offered that these are all the elements that could trigger actual final results to differ materially from the forward-looking statements. As a result, you should contemplate these elements in evaluating the forward-seeking statements incorporated herein, and not spot undue reliance on such statements.

Associated Stock Watch Content articles

Tags: , , , , , , ,